Belchin Kostov

EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapies

Manuel Ramos‐Casals, Pilar Brito‐Zerón, Stefano Bombardieri et al. · Annals of the Rheumatic Diseases · 2019 · 695 citations · Full text

Medicine, Dermatology, Internal Medicine +16

Effect of using reporting guidelines during peer review on quality of final manuscripts submitted to a biomedical journal: masked randomised trial

Erik Cobo, Jordi Cortés, Josep‐María Ribera et al. · BMJ · 2011 · 297 citations · Full text

Pharmacy, Literature, Comparative Effectiveness Research +16

Systemic involvement in primary Sjogren's syndrome evaluated by the EULAR-SS disease activity index: analysis of 921 Spanish patients (GEAS-SS Registry)

Manuel Ramos‐Casals, Pilar Brito‐Zerón, Roser Solans et al. · Lara D. Veeken · 2013 · 254 citations · Full text

Medicine, Internal Medicine, Neurology +17

Systemic activity and mortality in primary Sjögren syndrome: predicting survival using the EULAR-SS Disease Activity Index (ESSDAI) in 1045 patients

Pilar Brito‐Zerón, Belchin Kostov, Roser Solans et al. · Annals of the Rheumatic Diseases · 2014 · 204 citations · Full text

Medicine, Immunology, Internal Medicine +17

Characterization and risk estimate of cancer in patients with primary Sjögren syndrome

Pilar Brito‐Zerón, Belchin Kostov, G. Fraile et al. · Journal of Hematology & Oncology · 2017 · 153 citations · Full text

Medicine, Immunology, Oncology +17